We are live on
!
Find out more
HRCM
Hood River Capital Management Portfolio holdings
AUM
$9.98B
1-Year Est. Return
145.42%
This Fund
S&P 500
This Quarter
Est. Return
-0.25%
1 Year Est. Return
+145.42%
3 Year Est. Return
+584.57%
5 Year Est. Return
+927.1%
10 Year Est. Return
+12,185.37%
AUM
$3.11B
AUM Growth
-$246M
(-7.3%)
Cap. Flow
-$69.1M
Cap. Flow
% of AUM
-2.22%
Top 10 Holdings %
Top 10 Hldgs %
27.14%
Holding
151
New
30
Increased
61
Reduced
33
Closed
27
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FormFactor
FORM
|
+$44.1M |
| 2 |
AtriCure
ATRC
|
+$41.3M |
| 3 |
Fabrinet
FN
|
+$39.5M |
| 4 |
Inspire Medical Systems
INSP
|
+$35.1M |
| 5 |
Knife River
KNF
|
+$31.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MasTec
MTZ
|
+$63.1M |
| 2 |
Aehr Test Systems
AEHR
|
+$61.4M |
| 3 |
FIVE9
FIVN
|
+$56.8M |
| 4 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$53.1M |
| 5 |
NOVA
Sunnova Energy
NOVA
|
+$46.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.87% |
| 2 | Industrials | 23.7% |
| 3 | Healthcare | 22.96% |
| 4 | Financials | 9.63% |
| 5 | Consumer Discretionary | 6.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Axsome Therapeutics
AXSM
$11.4B
| $26.8M | 0.86% |
383,276
-1,085
| -0.3% | -$81.1K |
|
52
indie Semiconductor
INDI
$809M
| $24.7M | 0.79% |
3,914,939
+302,918
| +8% | +$2.34M |
|
|
BWIN
53
Baldwin Insurance Group
BWIN
$2.84B
| $24.3M | 0.78% |
1,046,426
+193,310
| +23% | +$4.84M |
|
54
CONMED
CNMD
$1.49B
| $23.8M | 0.76% |
236,127
+1,547
| +0.7% | +$178K |
|
55
Neurocrine Biosciences
NBIX
$16.5B
| $23.8M | 0.76% |
211,297
-1,793
| -0.8% | -$189K |
|
|
LOVE
56
LoveSac
LOVE
$257M
| $22.9M | 0.73% |
1,148,112
+99,869
| +10% | +$2.46M |
|
57
On Holding
ONON
$10.3B
| $20.9M | 0.67% |
750,763
-1,360,777
| -64% | -$43.1M |
|
58
Construction Partners
ROAD
$6.64B
| $20.6M | 0.66% |
+564,281
| New | +$18.6M |
|
|
BASE
59
DELISTED
Couchbase
BASE
| $19.7M | 0.63% |
1,145,981
+567,624
| +98% | +$9.29M |
|
60
BRC Group Holdings
RILY
$293M
| $19.3M | 0.62% |
471,202
+202,670
| +75% | +$9.98M |
|
61
Kulicke & Soffa
KLIC
$4.71B
| $19.3M | 0.62% |
397,137
+191,187
| +93% | +$10.1M |
|
|
CYBR
62
DELISTED
CyberArk
CYBR
| $18.8M | 0.6% |
+115,016
| New | +$18.5M |
|
|
KRTX
63
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $18.7M | 0.6% |
110,556
-142
| -0.1% | -$26.7K |
|
64
Genius Sports
GENI
$2.11B
| $18.4M | 0.59% |
3,456,744
+3,453,802
| +117,396% | +$22.9M |
|
65
Acadia Pharmaceuticals
ACAD
$5.07B
| $18.3M | 0.59% |
+877,827
| New | +$23.8M |
|
66
Arhaus
ARHS
$1.38B
| $17M | 0.54% |
+1,824,634
| New | +$19.1M |
|
67
RXO
RXO
$3.55B
| $16.9M | 0.54% |
855,627
-604,183
| -41% | -$11.9M |
|
68
Applied Optoelectronics
AAOI
$11.1B
| $16.7M | 0.54% |
+1,520,393
| New | +$16.1M |
|
69
i3 Verticals
IIIV
$329M
| $16.2M | 0.52% |
766,196
+12,319
| +2% | +$285K |
|
70
Ducommun
DCO
$3B
| $15.6M | 0.5% |
357,935
-17,134
| -5% | -$778K |
|
|
INFN
71
DELISTED
Infinera Corporation Common Stock
INFN
| $15.6M | 0.5% |
+3,725,030
| New | +$16.1M |
|
72
Camtek
CAMT
$7.48B
| $15.1M | 0.49% |
+242,761
| New | +$12M |
|
73
Cytokinetics
CYTK
$10.8B
| $14.8M | 0.48% |
502,526
-1
| -0% | -$33 |
|
74
Intapp
INTA
$3.07B
| $14.6M | 0.47% |
+435,717
| New | +$15.9M |
|
75
Dream Finders Homes
DFH
$1.3B
| $14.4M | 0.46% |
646,090
+530,528
| +459% | +$13.8M |
|
Similar funds
RI
HI
MF
RA
GI
ACA
MPI
URS
Hood River Capital Management's Q3 2023 Portfolio in Review
As of Q3 2023, Hood River Capital Management held 151 positions worth $3.11B, down 7.3% from $3.36B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Hood River Capital Management's Q3 2023 filing shows 30 new, 61 increased, 33 reduced and 27 closed positions. Its largest new stake was FormFactor: 1,312,587 shares worth $45.9M. The largest sale was MasTec, an estimated $63.1M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Industrials and Healthcare.
- Hood River Capital Management's largest Q3 2023 buy was FormFactor: 1,312,587 shares worth $45.9M.
- Hood River Capital Management added most to Rambus in Q3 2023, an estimated $29.6M increase.
- Hood River Capital Management's biggest Q3 2023 reduction was MasTec, cutting an estimated $63.1M.
- Hood River Capital Management fully exited FIVE9 in Q3 2023, selling an estimated $56.8M.
- Hood River Capital Management's ten largest holdings make up 27% of its $3.11B portfolio in Q3 2023.
- Hood River Capital Management opened 30 new positions and closed 27 in Q3 2023.
- Hood River Capital Management's portfolio value fell 7.3% quarter-over-quarter to $3.11B.
Based on Hood River Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.